Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Archivos De Cardiologia De Mexico|May 11, 2002
[Three-chamber pacemakers (ventricular resynchronization therapy)]Marco Antonio Peña DuqueArchivos De Cardiologia De Mexico|October 5, 2006
[Acute coronary ischemic syndrome without ST elevation. Role of glycoprotein IIB/IIIA inhibitors and percutaneous coronary interventions]Marco Antonio Peña DuqueGaceta Medica De Mexico|October 10, 2017
Primary thrombosis of the anterior descending in a patient with antiphospholipid antibody syndromeJorge Acuña-Valerio, Marco Antonio Peña-Duque, Álvaro Contreras-VillaseñorArchives of Medical Research|June 29, 2015
Coronary Atherosclerosis and Interventional CardiologyMarco Antonio Peña-Duque, José Luis Romero-Ibarra, Manuel Ben Adoniram Gaxiola-Macías, et al.Biomolecules|June 24, 2022
CASP1 Gene Polymorphisms and BAT1-NFKBIL-LTA-CASP1 Gene-Gene Interactions Are Associated with Restenosis after Coronary StentingGilberto Vargas-Alarcón, Julian Ramírez-Bello, Marco Antonio Peña-Duque, et al.Archivos De Cardiologia De Mexico|May 20, 2011
Intracardiac ultrasound-guided percutaneous mitral valvuloplastyMarco Antonio Peña-Duque, Carlos Zabal-Cerdeira, José Alejandro Amado-de León, et al.Archivos De Cardiologia De Mexico|October 2, 2012
[Cell therapy for ischemic heart disease]Carlos David Escobedo-Uribe, Adriana Elizabeth Monsiváis-Urenda, Juan Manuel López-Quijano, et al.Archivos De Cardiologia De Mexico|June 28, 2008
[Calculated pulmonary vascular resistance, is definitively a worthless variable. Current methods for a better definition]Eulo Lupi Herrera, Julio Sandoval Zárate, Jorge Gaspar Hernández, et al.Cytokine|April 13, 2011
Alleles and haplotypes of the interleukin 10 gene polymorphisms are associated with risk of developing acute coronary syndrome in Mexican patientsJosé Manuel Fragoso, Maite Vallejo, Edith Alvarez-León, et al.Pageof 4